Etoposide: four decades of development of a topoisomerase II inhibitor
- PMID: 9893622
- DOI: 10.1016/s0959-8049(98)00228-7
Etoposide: four decades of development of a topoisomerase II inhibitor
Abstract
Podophyllin-containing materials have been used as folk medicines for centuries. In the 1950s, scientists began a search to identify a more effective podophyllotoxin derivative. These efforts eventually resulted in the development of a new class of antineoplastic agents which target the DNA unwinding enzyme, topoisomerase II. The history of the development of one of the first identified topoisomerase II inhibitors, etoposide, is reviewed in this paper. Critical developments in etoposide's mechanism of action, pharmacology and administration schedule are summarised. The clinical benefits of the recently marketed etoposide prodrug, etoposide phosphate (Etopophos) are also detailed. The current status of other clinically approved anticancer agents which target topoisomerase II is briefly reviewed.
Similar articles
-
Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.Drug Saf. 2006;29(3):209-30. doi: 10.2165/00002018-200629030-00005. Drug Saf. 2006. PMID: 16524321 Review.
-
Topoisomerase II inhibitors.Cancer Chemother Biol Response Modif. 2003;21:103-25. doi: 10.1016/s0921-4410(03)21005-x. Cancer Chemother Biol Response Modif. 2003. PMID: 15338742 Review. No abstract available.
-
Etoposide sensitivity of radioresistant human glioma cell lines.Cancer Chemother Pharmacol. 1998;41(2):93-7. doi: 10.1007/s002800050713. Cancer Chemother Pharmacol. 1998. PMID: 9443620
-
Clinical applications of anticancer drugs targeted to topoisomerase II.Biochim Biophys Acta. 1998 Oct 1;1400(1-3):173-84. doi: 10.1016/s0167-4781(98)00134-1. Biochim Biophys Acta. 1998. PMID: 9748560 Review.
-
DNA topoisomerase II inhibitors.IARC Monogr Eval Carcinog Risks Hum. 2000;76:175-344. IARC Monogr Eval Carcinog Risks Hum. 2000. PMID: 11000976 Free PMC article. Review. No abstract available.
Cited by
-
Functional investigation of NCI-H460-inducible myofibroblasts on the chemoresistance to VP-16 with a microfluidic 3D co-culture device.PLoS One. 2013 Apr 16;8(4):e61754. doi: 10.1371/journal.pone.0061754. Print 2013. PLoS One. 2013. PMID: 23613925 Free PMC article.
-
The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects.ISRN Oncol. 2012;2012:902178. doi: 10.5402/2012/902178. Epub 2012 Dec 11. ISRN Oncol. 2012. PMID: 23304556 Free PMC article.
-
Physalin B not only inhibits the ubiquitin-proteasome pathway but also induces incomplete autophagic response in human colon cancer cells in vitro.Acta Pharmacol Sin. 2015 Apr;36(4):517-27. doi: 10.1038/aps.2014.157. Epub 2015 Mar 23. Acta Pharmacol Sin. 2015. PMID: 25832431 Free PMC article.
-
AMP-activated protein kinase - a journey from 1 to 100 downstream targets.Biochem J. 2022 Nov 30;479(22):2327-2343. doi: 10.1042/BCJ20220255. Biochem J. 2022. PMID: 36383046 Free PMC article.
-
Screening of Chonemorpha fragrans Bioactive Extracts for Cytotoxicity Potential and Inhibition Studies of Key Enzymes Involved in Replication.Pharmacogn Mag. 2016 May;12(Suppl 3):S297-302. doi: 10.4103/0973-1296.185708. Pharmacogn Mag. 2016. PMID: 27563215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources